Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma. [electronic resource]
Producer: 20180227Description: 156 p. digitalISSN:- 1471-2407
- Acetazolamide -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Benzamides -- pharmacology
- Carbonic Anhydrase Inhibitors -- pharmacology
- Cell Line
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Drug Therapy, Combination
- Female
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Mice
- Neuroblastoma -- drug therapy
- Pyridines -- pharmacology
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.